CANADIAN GERIATRICS SOCIETYNEWS & UPDATES |
WORLD GUIDELINES FOR FALLS AND PREVENTION MANAGEMENT We are proud to announce the publication of the World Guidelines for Falls Prevention and Management for Older Adults: A Global Initiative. Spearheaded by CGS Vice-President and CGS Falls, Balance, and Mobility Special Interest Group (SIG) Chair, Dr. Manuel Montero-Odasso, it aims to provide a framework and expert recommendations to healthcare and other professionals working with older adults on how to identify and assess the risk of falls. These guidelines were developed by the World Falls Task Force, which assembled 96 multidisciplinary experts from 39 countries across 5 continents, with representation from 36 scientific and academic societies, including the Canadian Geriatrics Society and several of its members. Click here to read the article.
CGS AWARDSWE ARE PLEASED TO ANNOUNCE THAT AWARD NOMINATIONS ARE NOW OPENED FOR: Peter McCracken Physician Innovator in Education Award Ronald Cape Distinguished Service Award NEW! B. Lynn Beattie Clinical Leadership Award The deadline for nominations is January 16, 2023.
2022 CGS ANNUAL SCIENTIFIC MEETINGThat’s a Wrap! We would like to thank all our delegates for attending the virtual CGS 2022 Annual Scientific Meeting! We hope you found the program both educational and informative, and that your virtual experience was pleasant. We encourage you to visit the online portal for ongoing information. The portal will remain active until April 2023.
CGS FUNDRAISING DRAWCongratulations to Marlene Smart for winning a free registration to the 2023 CGS Annual Scientific Meeting in Vancouver. We are pleased to announce that with your help - we have raised a total of $1671 towards the CGS Scholarship Foundation! Thank you to everyone who supported, donated and participated in the 2022 CGS fundraising draw. If you are interested in donating to the CGS Scholarship Foundation, please click here to donate!
Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab Aducanumab, a drug for treating Alzheimer’s disease, was recently approved by the FDA and is now under review for approval in Canada. | MEMBERSHIP RENEWAL REMINDERRemember to renew your CGS membership if you haven't already by going to your member profile! Thank you for your continuous support and for being a member of the Canadian Geriatrics Society. We are looking forward to another fantastic year! |
|
|
|
|
|
